MicroRNA-486 promotes a more catabolic phenotype in chondrocyte-like cells by targeting SIRT6 : possible involvement in cartilage degradation in osteoarthritis.
Chondrocyte catabolic phenotype
Osteoarthritis
SIRT6
SW1353 cell line
miR-486
Journal
Bone & joint research
ISSN: 2046-3758
Titre abrégé: Bone Joint Res
Pays: England
ID NLM: 101586057
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
entrez:
28
7
2021
pubmed:
29
7
2021
medline:
29
7
2021
Statut:
ppublish
Résumé
Osteoarthritis (OA) is characterized by persistent destruction of articular cartilage. It has been found that microRNAs (miRNAs) are closely related to the occurrence and development of OA. The purpose of the present study was to investigate the mechanism of miR-486 in the development and progression of OA. The expression levels of miR-486 in cartilage were determined by quantitative real-time polymerase chain reaction (qRT-PCR). The expression of collagen, type II, alpha 1 (COL2A1), aggrecan (ACAN), matrix metalloproteinase (MMP)-13, and a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS4) in SW1353 cells at both messenger RNA (mRNA) and protein levels was determined by qRT-PCR, western blot, and enzyme-linked immunosorbent assay (ELISA). Double luciferase reporter gene assay, qRT-PCR, and western blot assay were used to determine whether silencing information regulator 6 (SIRT6) was involved in miR-486 induction of chondrocyte-like cells to a more catabolic phenotype. Compared with osteonecrosis, the expression of miR-486 was significantly upregulated in cartilage from subjects with severe OA. In addition, overexpressed miR-486 promoted a catabolic phenotype in SW1353 cells by upregulating the expressions of ADAMTS4 and MMP-13 and down-regulating the expressions of COL2A1 and ACAN. Conversely, inhibition of miR-486 had the opposite effect. Furthermore, overexpression of miR-486 significantly inhibited the expression of SIRT6, confirming that SIRT6 is a direct target of miR-486. Moreover, SW1353 cells were transfected with small interfering RNA (si)-SIRT6 and it was found that SIRT6 was involved in and inhibited miR-486-induced changes to SW1353 gene expression. Our results indicate that miR-486 promotes a catabolic phenotype in SW1353 cells in OA by targeting SIRT6. Our findings might provide a potential therapeutic target and theoretical basis for OA. Cite this article:
Identifiants
pubmed: 34319136
doi: 10.1302/2046-3758.107.BJR-2019-0251.R4
pmc: PMC8333035
doi:
Types de publication
Journal Article
Langues
eng
Pagination
459-466Références
Curr Osteoporos Rep. 2018 Oct;16(5):611-616
pubmed: 30155845
Osteoarthritis Cartilage. 2014 Apr;22(4):566-77
pubmed: 24561281
Oncol Lett. 2018 Apr;15(4):5368-5374
pubmed: 29552180
Cell Physiol Biochem. 2017;42(6):2159-2168
pubmed: 28873368
Bone Joint Res. 2019 Aug 2;8(7):290-303
pubmed: 31463037
Biomaterials. 2018 Aug;173:47-57
pubmed: 29758546
Mol Med Rep. 2018 Jul;18(1):502-508
pubmed: 29749497
New Phytol. 2013 Jul;199(1):212-227
pubmed: 23627500
Bone Joint Res. 2018 Jul 7;7(6):414-421
pubmed: 30034795
Nucleic Acids Res. 2020 Jan 8;48(D1):D127-D131
pubmed: 31504780
Bone Joint Res. 2018 May 5;7(4):308-317
pubmed: 29922449
Oncotarget. 2016 Mar 29;7(13):15840-53
pubmed: 26895105
J Biol Chem. 2013 Apr 5;288(14):10061-10072
pubmed: 23417678
Pol J Vet Sci. 2017 Mar 28;20(1):189-201
pubmed: 28525322
J Proteome Res. 2016 Mar 4;15(3):1033-50
pubmed: 26794603
Scand J Pain. 2017 Jul;16:148-149
pubmed: 28850393
RNA. 2004 Oct;10(10):1507-17
pubmed: 15383676
Cell Oncol (Dordr). 2014 Jun;37(3):215-27
pubmed: 25027758
Biochem Biophys Res Commun. 2015 Oct 23;466(3):319-26
pubmed: 26362183
Bone Joint Res. 2018 Aug 4;7(7):494-500
pubmed: 30123499
Clin Cancer Res. 2011 May 1;17(9):2657-67
pubmed: 21415212
J Vis Exp. 2007;(7):264
pubmed: 18989435
J Orthop Res. 2003 Mar;21(2):282-9
pubmed: 12568960
Oncogene. 2014 Feb 27;33(9):1181-9
pubmed: 23474761
Biochem Biophys Res Commun. 2016 Jan 1;469(1):62-69
pubmed: 26612259
Osteoarthritis Cartilage. 2005 Aug;13(8):697-708
pubmed: 15950496
Osteoarthritis Cartilage. 2003 Apr;11(4):233-41
pubmed: 12681949
RNA. 2006 Jul;12(7):1161-7
pubmed: 16738409
Ageing Res Rev. 2017 Nov;40:20-30
pubmed: 28774716
Ann Surg Oncol. 2009 Aug;16(8):2339-50
pubmed: 19475450
Biomed Res Int. 2014;2014:648459
pubmed: 24959581
J Inflamm (Lond). 2015 Mar 28;12:24
pubmed: 25821409
Scand J Pain. 2017 Jul;16:74-88
pubmed: 28850416
Science. 2008 May 30;320(5880):1185-90
pubmed: 18483398
Orthop J Sports Med. 2017 Jun 20;5(6):2325967117711376
pubmed: 28680892
Bone Joint Res. 2018 May 5;7(4):298-307
pubmed: 29922448
Biochem Biophys Res Commun. 2008 Dec 12;377(2):668-673
pubmed: 18948085
PLoS One. 2014 Sep 17;9(9):e107577
pubmed: 25229425
Cell Oncol (Dordr). 2017 Aug;40(4):303-339
pubmed: 28748501
Nature. 2018 Aug;560(7720):661-665
pubmed: 30135584
Biochem Biophys Res Commun. 2008 Nov 7;376(1):86-90
pubmed: 18765229
Genome Biol. 2019 Jan 22;20(1):18
pubmed: 30670076
Elife. 2015 Aug 12;4:
pubmed: 26267216